ORIGINAL RESEARCH
Published on 15 Nov 2022
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience
doi 10.3389/fonc.2022.1026251
- 1,996 views
- 14 citations
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Targeted Therapies in Solid Malignancies: Mechanisms of Escape and Innovative Strategies
Targeted Therapies in Solid Malignancies: Mechanisms of Escape and Innovative Strategies
3,697
Total downloads
12k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 14 Nov 2022
Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
doi 10.3389/fphar.2022.1023533
- 3,073 views
- 12 citations
ORIGINAL RESEARCH
Published on 02 Nov 2022
ECM1 regulates the resistance of colorectal cancer to 5-FU treatment by modulating apoptotic cell death and epithelial-mesenchymal transition induction
doi 10.3389/fphar.2022.1005915
- 2,241 views
- 9 citations
BRIEF RESEARCH REPORT
Published on 06 May 2022
PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer
doi 10.3389/fphar.2022.890614
- 3,341 views
- 4 citations
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore